RT Journal Article
SR Electronic
T1 Projecting the seasonality of endemic COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.26.22269905
DO 10.1101/2022.01.26.22269905
A1 Jeffrey P. Townsend
A1 April D. Lamb
A1 Hayley B. Hassler
A1 Pratha Sah
A1 Aia Alvarez Nishio
A1 Cameron Nguyen
A1 Alison P. Galvani
A1 Alex Dornburg
YR 2022
UL http://medrxiv.org/content/early/2022/01/28/2022.01.26.22269905.abstract
AB Successive waves of infection by SARS-CoV-2 have left little doubt that this virus will transition to an endemic disease 1,2. Projections of the endemic seasonality of SARS-CoV-2 transmission are crucial to informed public health policy 3. Such projections are not only essential to well-timed interventions and the preparation of healthcare systems for synchronous surges with other respiratory viruses 4, but also to the elimination of seasonality as a confounder in the identification of surges that are occurring due to viral evolution, changes in host immunity, or other non-seasonal factors. However, the less than two-year duration of SARS-CoV-2 circulation, pandemic dynamics, and heterogeneous implementation of interventions have grievously complicated evaluations of its seasonality 5. Here we estimate the impending endemic seasonality of SARS-CoV-2 in global population centers via a novel phylogenetic ancestral and descendent states approach 6 that leverages long-term data on the incidence of circulating coronaviruses. Our results validate a major concern that endemic COVID-19 will typically surge coincident with other high-morbidity and -mortality respiratory virus infections such as influenza and RSV 7. In temperate locales in the Northern Hemisphere, we identify spatiotemporal surges of incidences that range from October through January in New York to January through March in Yamagata, Japan. This knowledge of likely spatiotemporal surges of COVID-19 is fundamental to optimal timing of public health interventions that anticipate the impending endemicity of this disease and mitigate SARS-CoV-2 transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Science Foundation of the United States of America RAPID 2031204 (JPT and AD), NSF Expeditions CCF 1918784 (JPT and APG), and support from the University of North Carolina, Charlotte to AD.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and materials availability All data, inferred phylogenetic trees, imputed monthly proportions, and code underlying this study are publicly available on Zenodo: DOI:10.5281/zenodo.5274735. https://zenodo.org/record/5274735#.YfGrBRPMIeY